PlaqueTec
Develops AI-driven precision medicine tools aimed at improving assessment and management of cardiovascular disease by supporting personalized diagnosis and treatment decisions.
Overview
PlaqueTec develops AI-driven precision medicine solutions focused on cardiovascular disease, positioning its products to support more personalized assessment and management of cardiac conditions. The company emphasizes precision medicine for cardiovascular care and markets its technology to stakeholders involved in diagnosis and treatment of heart disease. PlaqueTec is an early-stage, Cambridge-based venture that completed an undisclosed financing of €4.2 million (reported as $5M total raised) on April 27, 2026 to advance its precision medicine work in cardiovascular disease.
Funding History
Cambridge’s PlaqueTec raises €4.2 million to advance precision medicine for cardiovascular disease
Frequently Asked Questions
- How much has PlaqueTec raised in total?
- PlaqueTec has raised a total of $5M across 1 funding round.
- Who are PlaqueTec's investors?
- PlaqueTec's investors include Undisclosed.
- What does PlaqueTec do?
- PlaqueTec develops AI-driven precision medicine solutions focused on cardiovascular disease, positioning its products to support more personalized assessment and management of cardiac conditions. The company emphasizes precision medicine for cardiovascular care and markets its technology to stakeholders involved in diagnosis and treatment of heart disease. PlaqueTec is an early-stage, Cambridge-based venture that completed an undisclosed financing of €4.2 million (reported as $5M total raised) on April 27, 2026 to advance its precision medicine work in cardiovascular disease.
- Where is PlaqueTec headquartered?
- PlaqueTec is headquartered in Cambridge, United Kingdom.
Investors
Related Insights
A comprehensive analysis of Sage's funding history, investors, competitive position, and growth trajectory in the AI Healthcare space.
A data-driven analysis of AI funding across all 17 sectors — from Foundation Models to AI Healthcare — with sector totals, deal counts, top companies, and investment trends for 2026.
A comprehensive, data-driven analysis of AI venture funding in Q1 2026. $35.9 billion raised across 95 deals, with 15 mega-rounds capturing 85.5% of total capital. Europe breaks out with $6.65B, and billion-dollar seed rounds arrive for the first time.